UK doctors have reported a breakthrough in treating Huntington's disease, with a new gene therapy able to slow its progression by 75 percent. The treatment targets the faulty gene responsible for the devastating neurodegenerative condition that affects around 30,000 people in the UK alone.
In one of the most significant neuroscience breakthroughs of 2025, UK doctors have reported that a new gene therapy can slow the progression of Huntington's disease by an extraordinary 75 percent. This represents a transformative moment for patients and families affected by this cruel neurodegenerative condition, which gradually destroys nerve cells in the brain and has long been considered untreatable.
Huntington's disease is caused by a mutation in the HTT gene, which produces a toxic form of the huntingtin protein. This protein accumulates in brain cells over time, leading to progressive cognitive decline, involuntary movements, and psychiatric symptoms. Until now, treatments could only manage symptoms — not address the underlying cause.
“This represents a transformative moment for patients and families affected by this cruel neurodegenerative condition, which gradually destroys nerve cells in the brain and has long been considered untreatable.”
The new gene therapy works by silencing the faulty HTT gene, preventing the production of the toxic protein. Delivered directly to the brain through a one-time procedure, the treatment has shown remarkable results in clinical trials, with patients experiencing a dramatic slowing of disease progression compared to those receiving standard care.
For the estimated 30,000 people living with Huntington's disease in the UK — and hundreds of thousands worldwide — this development offers something previously unimaginable: real hope. Because Huntington's is hereditary, each child of a parent with the condition has a 50% chance of inheriting it, meaning the impact of this therapy extends across generations.
The research team, based at leading UK hospitals, has described the results as "beyond what we dared hope for." While the therapy does not yet constitute a cure, slowing the disease by 75% could mean years of additional quality life for patients — years spent with family, pursuing passions, and maintaining independence.
This breakthrough builds on decades of gene therapy research and represents the culmination of tireless work by scientists, clinicians, and patient advocates. Clinical trials are now expanding, and researchers are optimistic that further refinements could yield even better outcomes. For the Huntington's community, the message is clear: science has not given up on them, and the future looks brighter than ever.
How did this story make you feel?
